Duration of Protection of Nirsevimab Against Hospitalisation for Respiratory Syncytial Virus Infection
Duration of Protection of Nirsevimab Against Hospitalisation for Respiratory Syncytial Virus Infection
Active, not recruiting · NCT06993753 · Registry updated 2025-05-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Duration of Protection of Nirsevimab Against Hospitalisation for Respiratory Syncytial Virus Infection | Infections | Active, not recruiting | Not stated | 2025-05-29 | NCT06993753 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Griffith University | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Griffith University | Gold Coast | Australia | 1 |